Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors

Details for Australian Patent Application No. 2009228943 (hide)

Owner Janssen Pharmaceutica NV

Inventors Mevellec, Laurence Anne; Roux, Bruno; Angibaud, Patrick Rene; Storck, PierreHenri; Vialard, Jorge Eduardo; Meyer, Christophe

Agent Shelston IP

Pub. Number AU-A-2009228943

PCT Pub. Number WO2009/118382

Priority 08153432.3 27.03.08 EP

Filing date 26 March 2009

Wipo publication date 1 October 2009

International Classifications

C07D 221/12 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/118382 Priority application(s): WO2009/118382

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228945-Quinazolinone derivatives as tubulin polymerization inhibitors

2009228938-Biodegradable polyester, preparation process thereof and products comprising said polyester